Peripheral Artery Disease Market Research Reveals Path To $6.69 Billion By 2030

The peripheral artery disease (PAD) market is on track for substantial growth as advancements in medical technology and increasing awareness drive demand. With innovations in treatment options and expanding healthcare infrastructure, the market is evolving rapidly, offering promising opportunities for both industry players and patients alike.

Forecasted Expansion and Market Size of the Peripheral Artery Disease Market
The peripheral artery disease market is anticipated to reach a value of $6.69 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.8%. This robust growth is propelled by several factors, including progress in minimally invasive peripheral interventions and a wider adoption of drug-eluting balloons and stents. Furthermore, the expansion of hospitals and specialized vascular clinics is enhancing patient access to care. Increased public awareness and early detection programs, along with the rising use of combination therapies that incorporate lifestyle changes and pharmacotherapy, are also contributing to market growth. Emerging trends such as the use of artificial intelligence for early diagnosis and risk evaluation, cloud-based systems for patient monitoring, genomic-guided personalized therapies, IoT integration for post-treatment follow-up, and smart manufacturing processes in PAD device production are expected to further influence the market during the forecast period.

The peripheral artery disease market size has grown strongly in recent years. It will grow from $4.62 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to high prevalence of peripheral artery disease, limited awareness of PAD risk factors, reliance on traditional medications, inadequate access to interventional specialists, fragmented patient care pathways.

Download a free sample of the peripheral artery disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Fueling Growth in the Peripheral Artery Disease Market
Innovations in minimally invasive treatment techniques, such as the development of drug-eluting balloons and stents, are playing a significant role in expanding the PAD market. These technologies improve procedural outcomes and reduce complication rates, making them more appealing to both physicians and patients. Alongside this, the growth of hospitals and specialty vascular clinics is making advanced treatments more accessible to a larger patient base, supporting market expansion.

Another important driver is the heightened awareness of peripheral artery disease among patients and healthcare providers. Early detection initiatives and combination therapies that include lifestyle modifications and pharmacological interventions are contributing to better management of the disease, thereby increasing demand for PAD-related products and services. This increased focus on comprehensive care is an important factor encouraging market growth.

View the full peripheral artery disease market report:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Players Influencing the Peripheral Artery Disease Market
The peripheral artery disease market features a competitive landscape shaped by several prominent companies, including:
Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V., B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton dic*kinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., and Avinger Inc.

In a notable move in April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc., a US-based medical device company specializing in peripheral artery disease products. This acquisition expands Abbott's portfolio in both peripheral and coronary artery disease by integrating Cardiovascular Systems' innovative atherectomy technologies.

Innovations and Future Trends Shaping the Peripheral Artery Disease Market
Companies in the PAD market are focusing heavily on innovation, particularly in developing dissolvable drug-eluting scaffold systems. These novel devices aim to offer safer and more effective treatment options for below-the-knee arterial blockages. Unlike traditional metallic stents, these resorbable scaffolds provide temporary vessel support and gradually dissolve, reducing long-term complications.

Illustrating this trend, Abbott Laboratories introduced the Esprit BTK Everolimus Eluting Resorbable Scaffold System in April 2024. This pioneering dissolvable stent releases everolimus to prevent re-narrowing of blood vessels and fully resorbs over time. It presents an advanced alternative to conventional angioplasty or permanent stenting, especially for patients with complex lesions or critical limb ischemia, by enhancing vessel healing and minimizing risks associated with permanent metal implants.

Detailed Breakdown of the Peripheral Artery Disease Market by Segments
This report segments the peripheral artery disease market into the following categories:
1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories.
2) By Drug Categories: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytic Agents, and Anti-Inflammatory Agents.
3) By Route of Administration: Oral, Parenteral, and Other Routes.
4) By End Users: Hospitals, Specialty Clinics, and Other End User Categories.

Further subsegments include:
- Peripheral Angioplasty Balloons broken down into Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, and Cutting Balloons.
- Peripheral Stents divided into Drug-Eluting Stents, Bare Metal Stents, and Covered Stents.
- Peripheral Catheters categorized into Sheath Introducers, Guidewires, Diagnostic Catheters, and Delivery Catheters.
- Inferior Vena Cava Filters separated into Retrievable and Permanent types.
- Plaque Modification Devices including Atherectomy, Laser Atherectomy, and Rotational Atherectomy Devices.
- Hemodynamic Flow Alteration Devices classified as Flow Diversion and Flow Restriction Devices.
- Peripheral Accessories encompassing Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, and Support Devices.

This detailed segmentation provides a comprehensive view of the PAD market's structure and the various product and drug categories that cater to different treatment needs.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.